Elamipretide for Mytochondrial Myopathy
Dr. Amel Karaa discusses the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies. Show references: https://n.neurology.org/content/101/3/e238
28 Heinä 20232min
Sarepta Announces FDA Approval of ELEVIDYS
Dr. Hoda Abdel-Hamid discusses the recent FDA approval for the first-ever gene therapy for Duchenne muscular dystrophy.
27 Heinä 20231min
Anti-Seizure Medication
Dr. Irfan Sheikh sheds light on the usage of anti-seizure medications within the inpatient setting.
26 Heinä 20233min
Cognitive Decline Following Heart Attack
Dr. Rae Bacharach discusses the Neurology Today article, "Cognitive Decline Appears to Speed Up in the Years Following a Heart Attack". Show references: https://journals.lww.com/neurotodayonline/fullt...
25 Heinä 20232min
Traumatic Brain Injury in Children
Dr. Halley Alexander discusses the paper, "It's Been a TRACK-TBI LONG Time Coming, but Well Worth the Wait". Show references: https://n.neurology.org/content/early/2023/06/21/WNL.0000000000207682
24 Heinä 20233min
New Treatment for IDH Mutant Gliomas
Dr. Ingo K. Mellinghoff discusses his paper, "Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma". Show references: https://pubmed.ncbi.nlm.nih.gov/37272516/
21 Heinä 20231min
Patient-Assistance Programs, Kickbacks, and the Courts
Dr. Jacob T. Elberg discusses his paper, "Patient-Assistance Programs, Kickbacks, and the Courts". Show references: https://www.nejm.org/doi/full/10.1056/NEJMp2303535
20 Heinä 20233min
Neurologic Complications of Cardiac and Pulmonary Disease: Part 3
In Part 3 of a 3-part series, Shraddha Mainali, MD, discusses her article, "Neurologic Complications of Cardiac and Pulmonary Disease" from the June Continuum Neurology of Systemic Disease issue. This...
19 Heinä 20232min
